Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CMMB
#4815
Chemomab Therapeutics Ltd. American Depositary Share
1.680
0
USD
-0.59%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-0.59%
Changement Mensuel
-13.40%
Evolution sur 6 mois
+13.90%
Changement Annuel
+13.90%
Clôture Précédente
1.690
0
Open
1.680
0
Bid
Ask
Low
1.680
0
High
1.680
0
Volume
2
Marchés
Actions des Marchés US
Soins de Santé
CMMB
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q4, 25
Total assets
16.96 M
13.81 M
Total liabilities
3.43 M
1.48 M
Total equity
13.54 M
12.33 M
Total liabilities & shareholders' equities
16.96 M
13.81 M
Total debt
—
—
Net debt
—
—
Nouvelles
Le nebokitug de Chemomab montre un potentiel modificateur de la maladie dans l’essai sur la CSP
Chemomab’s nebokitug shows disease-modifying potential in PSC trial
Chemomab reports positive 48-week data for PSC drug nebokitug
ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition
Best Momentum Stocks to Buy for Oct. 23
New Strong Buy Stocks for Oct. 23: MQ, GES and More
SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study
Roche's Gazyva Secures FDA Nod for Label Expansion in Lupus Nephritis
NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients
ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up
NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs
Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan